New gut bacteria therapy shows promise for colitis
Disease control
Completed
This early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it settles in the body. Researchers also looked for early signs that it might help control the disease.
Phase: PHASE1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated May 17, 2026 08:54 UTC